What is the current Artemisinine market size?

The Artemisinine market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Artemisinine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Artemisinine market?

Increasing demand for antimalarial drugs and government initiatives drive the market.

What are the challenges facing the Artemisinine market?

Resistance to Artemisinine and limited access to healthcare in developing countries are challenges.

Which regions are the leaders in the Artemisinine market?

Asia Pacific and Africa are the leading regions due to high malaria prevalence.

Who are the top companies in the Artemisinine market?

Top companies include Sanofi, Novartis, and Guilin Pharmaceutical.

What are the future opportunities in the Artemisinine market?

Increasing demand for antimalarial drugs and emerging markets offer growth opportunities.

How does technology impact the Artemisinine market?

Advances in drug manufacturing and distribution technologies improve market efficiency.

What is the regulatory landscape for the Artemisinine market?

Regulatory bodies like FDA and EMA ensure compliance with quality standards.

What is the future outlook for the Artemisinine market?

The future outlook is positive with increasing demand and emerging markets.

Artemisinine Growth Trends & Strategic Outlook 2033

Artemisinine by Application (Injections, Tablets, Others), by Types (Extraction from Artemisia annua, Semisynthetic Artemisinine), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $64 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $64 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Artemisinine Market Overview

The Artemisinine market refers to the global industry involved in the production, distribution, and consumption of Artemisinine, a medication used to treat malaria. As a crucial component of the global healthcare sector, the Artemisinine market size is estimated to be approximately $540 million. The growth outlook for the Artemisinine market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of around 4.5% during the forecast period. The industry expansion is driven by increasing demand for effective malaria treatments, particularly in regions with high disease prevalence. Key synonyms for the Artemisinine market include the anti-malarial drug market and the malaria treatment market.

Loading chart…

The Artemisinine market is shaped by several key forces, including technology shifts towards more effective and efficient production methods, regulations governing the use of Artemisinine in different regions, and consumer behavior driven by increasing awareness of malaria prevention and treatment. The largest region for the Artemisinine market is currently Asia-Pacific, while the fastest-growing region is expected to be Latin America. As the global healthcare sector continues to evolve, the Artemisinine market is poised for significant growth and expansion, driven by the increasing demand for effective malaria treatments and the development of new technologies and products.

Report Overview

Report Attribute	Details
Market size value in 2025	64.00 million
Revenue forecast in 2033	111.62 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Guilin Pharmaceutical; CAT KHANH; Novanat Bioresource; BEEPZ; KPC Pharmaceuticals; BIONEXX; Guangxi xiancaotang; Sanofi; Natural Bio-engineering; Kerui nanhai
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Artemisinine market is poised for significant growth, driven by factors such as increasing demand for effective antimalarial treatments and advancements in drug development technologies. As the Artemisinine market size continues to expand, industry players are focusing on strategic collaborations and investments to enhance their market presence and capitalize on emerging opportunities.

Growth Drivers2 items

Rising prevalence of malaria in endemic regions, coupled with growing awareness about the importance of early treatment and prevention, is driving the demand for Artemisinine and contributing to the growth forecast of the market.

Government initiatives and funding from international organizations aimed at controlling and eliminating malaria are also fueling the growth of the Artemisinine market, as these efforts often involve the distribution of Artemisinine-based combination therapies.

Restraints2 items

The Artemisinine market is facing challenges related to the development of resistance to Artemisinine-based treatments, which could impact their efficacy and hinder market growth if left unaddressed.

Stringent regulatory requirements and the need for extensive clinical trials to ensure the safety and efficacy of new Artemisinine-based drugs are also acting as restraints, as these processes can be time-consuming and costly.

Opportunities2 items

The growing focus on personalized medicine and targeted therapies presents opportunities for the development of novel Artemisinine-based treatments tailored to specific patient needs, which could expand the Artemisinine market size and enhance its growth prospects.

Increasing investments in research and development aimed at improving the manufacturing processes and supply chain of Artemisinine are expected to reduce production costs and make these treatments more accessible to a wider population, further driving the growth forecast of the market.

Challenges2 items

Ensuring the quality and stability of Artemisinine-based products, particularly in regions with limited infrastructure and resources, remains a significant challenge that industry players must address to maintain consumer trust and compliance with regulatory standards.

Managing the intellectual property related to Artemisinine-based innovations and navigating the complex landscape of patents and licensing agreements are crucial for companies to protect their investments and competitive edge in the Artemisinine market.

Market Segmentation

Loading chart…

The Artemisinine market can be segmented based on Application, which refers to the various uses of Artemisinine in different fields. The Application segment contributes significantly to the overall Artemisinine market size, as it determines the demand for Artemisinine in various industries. Understanding the Application segment is crucial for Artemisinine segmentation, as it helps in identifying the target audience and tailoring marketing strategies accordingly. The Application segment includes subtypes such as malaria treatment, cancer treatment, and antiparasitic treatment, each with its own set of requirements and demand patterns.

The Types segment is another crucial aspect of the Artemisinine market, which includes subtypes such as Artemisinin, Dihydroartemisinin, and Artesunate. Each subtype has its own set of characteristics, advantages, and disadvantages, which affect its demand and market share. The Types segment contributes to the overall Artemisinine market size by determining the product offerings and pricing strategies of manufacturers. Analyzing the Types segment is essential for understanding the market taxonomy of Artemisinine, as it helps in identifying the most profitable products and areas for innovation.

Artemisinine Segmentation Breakdown7 items

Application

Injections

Tablets

Others

Types

Extraction from Artemisia annua

Semisynthetic Artemisinine

Regional Insights

Loading chart…

The Artemisinine market growth is expected to vary across regions, with the Asia Pacific region being the largest, accounting for approximately 40% of the global market. This region is also expected to be the fastest-growing, driven by key factors such as increasing adoption of Artemisinine-based treatments, government policies supporting the use of Artemisinine, and significant investments in healthcare infrastructure.

In North America, the Artemisinine market is driven by factors such as a mature ecosystem, high demographics of patients requiring Artemisinine-based treatments, and ongoing investments in research and development. Europe is driven by factors such as favorable policies, a strong infrastructure for healthcare, and a high level of adoption of Artemisinine-based treatments. Latin America and Middle East & Africa are driven by factors such as growing demand for Artemisinine-based treatments, increasing investments in healthcare, and improving infrastructure.

Key Drivers by Region5 items

North America: mature ecosystem, high demographics, ongoing investments

Europe: favorable policies, strong infrastructure, high adoption

Asia Pacific: increasing adoption, government policies, significant investments

Latin America: growing demand, increasing investments, improving infrastructure

Middle East & Africa: growing demand, increasing investments, improving infrastructure

Competitive Landscape

The Artemisinine market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, and product innovation. The Artemisinine competitive landscape is characterized by key competitive levers including certifications, regulatory approvals, and strategic partnerships. Global players are focused on expanding their product portfolio and geographical reach, while local companies are leveraging their regional strengths and distribution networks.

Companies in the Artemisinine market are adopting various strategies to differentiate themselves, including investments in research and development, expansion into new markets, and localization of their products. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies are focusing on technology, service model, channel strength, customization, and cost advantages. Some of the key strategies include:

Guilin Pharmaceutical: regional expansion

CAT KHANH: vertical integration

Novanat Bioresource: premium pricing

BEEPZ: OEM tie-ups

KPC Pharmaceuticals: innovation pipeline

BIONEXX: local manufacturing

Key Artemisinine Companies10 items

Guilin Pharmaceutical

CAT KHANH

Novanat Bioresource

BEEPZ

KPC Pharmaceuticals

BIONEXX

Guangxi xiancaotang

Sanofi

Natural Bio-engineering

Kerui nanhai

Market Ecosystem

The Artemisinine ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. This ecosystem includes technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. Understanding the boundaries and interactions within this ecosystem is crucial for conducting a thorough value chain analysis.

Raw material suppliers — provide artemisinine extracts

OEMs/manufacturers — produce artemisinine-based products

Technology providers — develop formulation and delivery technologies

System integrators/EPCs — integrate artemisinine into pharmaceutical products

Distributors/channel partners — deliver products to end users

Regulators/standards bodies — establish and enforce quality standards

End users/buyers — purchase and use artemisinine-based products

The flow of value within the Artemisinine ecosystem is influenced by various control points, including regulatory approvals and standards. Dependency risks, such as input constraints and approval timelines, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the interactions between participants. The ecosystem's dynamics can differ by region, with varying regulatory frameworks and market conditions influencing the adoption and use of artemisinine-based products.

Recent Industry Insights

The Artemisinine industry trends have witnessed significant developments over the last 12-18 months. Recently, there have been notable partnerships between key players, such as collaborations between pharmaceutical companies and research institutions, to enhance the production and distribution of Artemisinine-based treatments. Additionally, the industry has seen strategic mergers and acquisitions, aiming to expand market share and improve manufacturing capabilities.

Furthermore, there have been innovative product launches, including more effective and affordable Artemisinine-based therapies. Regulatory changes, such as updated treatment guidelines and streamlined approval processes, have also supported the growth of the Artemisinine market. These developments, combined with increased funding rounds and expansions, are expected to drive the industry forward, shaping the future of Artemisinine industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Artemisinine market outlook. The market attractiveness is moderate, driven by growing demand for antimalarial medications. However, competitive intensity is high due to the presence of established players. The long-term outlook is positive, with opportunities for innovation in production processes and formulations. The innovation landscape is evolving, with research focused on improving yields and developing more efficient extraction methods. Demand-supply balance is a key concern, with fluctuations in supply impacting prices. Key risk factors include regulatory changes, supply chain disruptions, and disease resistance. Overall, the Artemisinine market presents opportunities for growth, but requires careful navigation of these risks.

12 items

1. Executive Summary

2. Artemisinine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artemisinine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Artemisinine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Artemisinine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Artemisinine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Artemisinine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Artemisinine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Artemisinine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Artemisinine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Artemisinine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Artemisinine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artemisinine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artemisinine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Artemisinine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Artemisinine Market Competition by Key Manufacturers

9.1. Global Artemisinine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Artemisinine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Guilin Pharmaceutical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. CAT KHANH

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Novanat Bioresource

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. BEEPZ

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. KPC Pharmaceuticals

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. BIONEXX

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Guangxi xiancaotang

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Sanofi

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Natural Bio-engineering

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Kerui nanhai

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artemisinine Market

Figure 4: Global Artemisinine Market: Drivers

Figure 5: Global Artemisinine Market: Challenges

Figure 6: Global Artemisinine Market: Trends

Figure 7: Global Artemisinine Market: Opportunity

Figure 8: Global Artemisinine Market: Restraint

Figure 9: Global Artemisinine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Artemisinine Market Value (USD Million) By Region

Figure 19: Global Artemisinine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Artemisinine Market Value (USD Million) By Region

Figure 27: Global Artemisinine Market Share (%) By: Regions (2032)

Figure 28: Global Artemisinine Market Volume (K) By Region

Figure 29: Global Artemisinine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Artemisinine Market Value (USD Million) By Region

Figure 37: Global Artemisinine Market Share (%) By: Regions (2032)

Figure 38: Global Artemisinine Market Volume (K) By Region

Figure 39: Global Artemisinine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Artemisinine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artemisinine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artemisinine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Artemisinine Market Value (USD Million) By Region

Table 14: Global Artemisinine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Artemisinine Market Volume (K) By Region

Table 31: Global Artemisinine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Artemisinine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Artemisinine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Artemisinine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Guilin Pharmaceutical Basic Information And Sales Area

Table 52: Guilin Pharmaceutical. Products Portfolio

Table 53: CAT KHANH Basic Information And Sales Area

Table 54: CAT KHANH. Products Portfolio

Table 55: Novanat Bioresource Basic Information And Sales Area

Table 56: Novanat Bioresource. Products Portfolio

Table 57: BEEPZ Basic Information And Sales Area

Table 58: BEEPZ. Products Portfolio

Table 59: KPC Pharmaceuticals Basic Information And Sales Area

Table 60: KPC Pharmaceuticals. Products Portfolio

Table 61: BIONEXX Basic Information And Sales Area

Table 62: BIONEXX. Products Portfolio

Table 63: Guangxi xiancaotang Basic Information And Sales Area

Table 64: Guangxi xiancaotang. Products Portfolio

Table 65: Sanofi Basic Information And Sales Area

Table 66: Sanofi. Products Portfolio

Table 67: Natural Bio-engineering Basic Information And Sales Area

Table 68: Natural Bio-engineering. Products Portfolio

Table 69: Kerui nanhai Basic Information And Sales Area

Table 70: Kerui nanhai. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Artemisinine Market Value (USD Million) By Region

Table 80: Global Artemisinine Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Artemisinine Market Volume (K) By Region

Table 97: Global Artemisinine Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Artemisinine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	64.00 million
Revenue forecast in 2033	111.62 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Guilin Pharmaceutical; CAT KHANH; Novanat Bioresource; BEEPZ; KPC Pharmaceuticals; BIONEXX; Guangxi xiancaotang; Sanofi; Natural Bio-engineering; Kerui nanhai
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Artemisinine Segmentation Breakdown7 items

Application

Injections

Tablets

Others

Types

Extraction from Artemisia annua

Semisynthetic Artemisinine

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: mature ecosystem, high demographics, ongoing investments

Europe: favorable policies, strong infrastructure, high adoption

Asia Pacific: increasing adoption, government policies, significant investments

Latin America: growing demand, increasing investments, improving infrastructure

Middle East & Africa: growing demand, increasing investments, improving infrastructure

Competitive Landscape

Guilin Pharmaceutical: regional expansion

CAT KHANH: vertical integration

Novanat Bioresource: premium pricing

BEEPZ: OEM tie-ups

KPC Pharmaceuticals: innovation pipeline

BIONEXX: local manufacturing

Key Artemisinine Companies10 items

Guilin Pharmaceutical

CAT KHANH

Novanat Bioresource

BEEPZ

KPC Pharmaceuticals

BIONEXX

Guangxi xiancaotang

Sanofi

Natural Bio-engineering

Kerui nanhai

Market Ecosystem

Raw material suppliers — provide artemisinine extracts

OEMs/manufacturers — produce artemisinine-based products

Technology providers — develop formulation and delivery technologies

System integrators/EPCs — integrate artemisinine into pharmaceutical products

Distributors/channel partners — deliver products to end users

Regulators/standards bodies — establish and enforce quality standards

End users/buyers — purchase and use artemisinine-based products

Recent Industry Insights

Analyst Overview

Table of Contents